RxDoctor Payments Data

Duane Sipes, MD

Family Medicine · Greencastle, PANPI 1346229945

Payments from drug & device makers

$232in general payments, 2019–2025

Across 11 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$36
  • Radius Health, Inc.$31
  • Lilly USA, LLC$26
  • Boston Scientific$24
  • Abbott$23
  • AbbVie$20
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$232100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$232 in reported general payments places this provider in the 45th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$109,743
Medicare patients
299
Services billed
1,241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$110,928
JardianceEmpagliflozin52$51,297
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$28,131
Trijardy XrEmpaglifloz/Linaglip/Metformin28$25,802
XareltoRivaroxaban21$15,807
TradjentaLinagliptin14$14,868
MyrbetriqMirabegron17$11,228
ArexvyRsvpref3 Antigen/As01e/Pf36$10,838
Breo ElliptaFluticasone/Vilanterol19$10,566
ShingrixVaricella-Zoster Ge/As01b/Pf36$7,928
LinzessLinaclotide11$7,821
Duloxetine Hcl243$7,665
EntrestoSacubitril/Valsartan13$7,493
Tresiba Flextouch U-100Insulin Degludec11$5,852
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$5,088

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Synthroid$20$9,34850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Greencastle

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →